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Group A streptococcus (Streptococcus pyogenes) is the causative
agent of severe invasive infections such as necrotizing fasciitis
(the so-called ‘flesh eating disease’) and toxic-shock syndrome.
Spy1600, a glycoside hydrolase from family 84 of the large super-
family of glycoside hydrolases, has been proposed to be a virul-
ence factor. In the present study we show that Spy1600 has no
activity toward galactosaminides or hyaluronan, but does remove
β-O-linked N-acetylglucosamine from mammalian glycoproteins
– an observation consistent with the inclusion of eukaryotic
O-glycoprotein 2-acetamido-2-deoxy-β-D-glucopyranosidases
within glycoside hydrolase family 84. Proton NMR studies,
structure–reactivity studies for a series of fluorinated analogues
and analysis of 1,2-dideoxy-2′-methyl-α-D-glucopyranoso-
[2,1-d]-2′ -thiazoline as a competitive inhibitor reveals that
Spy1600 uses a double-displacement mechanism involving sub-
strate-assisted catalysis. Family 84 glycoside hydrolases are
therefore comprised of both prokaryotic and eukaryotic β-N-
acetylglucosaminidases using a conserved catalytic mechanism
involving substrate-assisted catalysis. Since these enzymes do not
have detectable hyaluronidase activity, many family 84 glycoside
hydrolases are most likely incorrectly annotated as hyaluronidases.
Key words: β-N-acetylglucosaminidase (GlcNAcase), mam-
malian glycoproteins, 1,2-dideoxy-2′-methyl-α-D-glucopyra-
noso-[2,1-d]-2′ -thiazoline (NAG-thiazoline), O-glycoprotein
2-acetamido-2-deoxy-β-D-glucopyranosidase (O-GlcNAcase),
O-glycoprotein 2-acetamido-2-deoxy-β-D-glucopyranoside (O-
GlcNAc), Spyl600, substrate-assisted catalysis.
INTRODUCTION
Family 84 glycoside hydrolases [1] are a group of enzymes found
in higher eukaryotes and pathogenic or symbiotic bacteria. The
first family 84 glycoside hydrolase cloned was identified as a
tumour-associated antigen termed MGEA5 (meningioma ex-
pressed antigen 5) [2]. This enzyme had most likely been prev-
iously isolated as hexosaminidase C [3] and shown to have exo-
β-N-acetylglucosaminidase activity. Further studies [4] using
protein purified from rat brain defined this enzyme as
O-GlcNAcase (O-glycoprotein 2-acetamido-2-deoxy-β-D-gluco-
pyranosidase), a key regulatory enzyme responsible for medi-
ating the removal of O-GlcNAc [O-linked GlcNAc (N-acetyl-
glucosamine, 2-acetamido-2-deoxy-D-glucopyranose)] from
serine and threonine residues of post-translationally modified
proteins [5]. The rat brain O-GlcNAcase was later cloned and
found to be identical with MGEA5 in sequence, and it has
been proposed that this enzyme has both O-GlcNAcase and
hyaluronidase activity [6]. Preliminary studies of the family 84
NagH enzyme from Clostridium perfringens have also suggested
that this enzyme is a hyaluronidase [7]. On the basis of these
studies, several members of this family of enzymes have been
annotated as hyaluronidases. Human family 84 O-GlcNAcase
has been shown to use a substrate-assisted catalytic mechanism
to effect removal of O-GlcNAc residues from proteins [8], a
mechanism in which the 2-acetamido group of the substrate
acts as a nucleophile to form a bicyclic oxazoline intermediate
(Scheme 1). This is in contrast with some other hexosaminidases,
such as the bacterial GlcNAcases (β-N-acetylglucosaminidases)
from glycoside hydrolase family 3 that, instead, use an enzymatic
nucleophile [9]. Recently, X-ray structural studies of two bac-
terial family 84 enzymes have given strong support to the sub-
strate-assisted catalytic mechanism for family 84 enzymes
[10,11] yet, despite genome annotations, no unambiguous studies
have addressed whether family 84 glycosidases do genuinely
process hyaluronan [6].
As part of an ongoing study into virulence factors from the
human pathogen group A streptococcus, we are interested in
Spy1600, a family 84 glycoside hydrolase from this organism.
Group A streptococcus causes severe invasive infections such
as necrotizing fasciitis and toxic-shock syndrome [12], and it
has recently been estimated that these organisms cause half a
million deaths each year [13]. The streptococcal family 84 enzyme
has been shown to be up-regulated during phagocytosis and has,
accordingly, been implicated as a virulence factor [14]. To better
understand this putative virulence factor as well as to facilitate the
design of potential inhibitors of this enzyme that could eventually
prove useful in a clinical setting, we have undertaken a series
of studies of this enzyme. In the present study we describe the
cloning, recombinant overexpression and purification, studies on
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Scheme 1 Retentive double-displacement catalytic mechanism used by
family 20 and family 84 GlcNAcases
the stereochemical outcome of the enzyme catalysed reaction,
substrate structure–function studies and inhibition studies.
Collectively, these studies show that Spy1600, in common with
eukaryotic O-GlcNAcases, uses substrate-assisted catalysis. This
enzyme is also capable of cleaving O-GlcNAc from post-
translationally modified proteins, opening up the possibility that
it may encounter this modification during the life cycle of
the bacterium. Furthermore, despite annotation as a putative
hyaluronidase, we show that Spy1600 displays no detectable
hyaluronidase activity, suggesting that glycoside hydrolase family
84 comprises GlcNAcases and not, as implied by genomic anno-
tations, hyaluronidases.
EXPERIMENTAL
Materials
All materials were purchased from Sigma–Aldrich, unless stated
otherwise. All methods followed the manufacturer’s instructions,
where given, or were performed as described by Sambrook et al.
[15].
Methods
Amplification and cloning of the ORF (open reading frame) encoding Spy1600,
a family 84 glycoside hydrolase from Streptococcus pyogenes M1 GAS SF370
The amino acid sequence of Spy1600 was checked for the
presence of a signal peptide using the SignalP 3.0 server [16]
and for common protein domains using the Pfam database [17].
The coding sequence, spy1600, was amplified from genomic
DNA from S. pyogenes SF370 (A.T.C.C. 700294; [18]) using
the following primers: 5′- CAT ATG ACC ATT TAT CAC GCC
TTA AAG -3′ and 5′- GGA TCC GAT TCG TAT CAG AAG
GCC AGA AC -3′. The amplified product was cloned into pCR-
Blunt (Invitrogen), then subcloned into pET-28a (Novagen) on
an Nde I–Bam HI fragment, and the resulting plasmid designated
pSpy1600. The conditions used for amplification were as specified
for use with Platinum Pfx DNA polymerase (Invitrogen).
Production and purification of Spy1600
N-terminally hexahistidine-tagged Spy1600 was produced via
induction of Escherichia coli BL21 (DE3; Novagen) cultures
carrying pSpy1600 following a protocol described in Brown
et al. [19] for expression of a different protein, except cultures
were grown at 20 ◦C post-induction. The recombinant protein
product was purified via affinity chromatography using nickel-
charged SepharoseTM chelating fast flow resin (GE Healthcare)
as described in the manufacturer’s instructions. The fractions
containing pure protein were concentrated, exchanged into
18.2 M/cm water using a 30 kDa-cut-off concentrator unit (Viva
Science), and the protein concentration determined according
to the method of Bradford [20], using BSA as a standard.
The purity of Spy1600 was judged by SDS/PAGE [21] and static
Figure 1 Fluorinated substrates and the inhibitor used in the present study
(A) Structure of the N-fluoroacetyl derivatives of MU-GlcNAc (n = 0–3, m = 0–3); (B) structure
of the NAG-thiazoline inhibitor.
nanospray ion-trap MS (ThermoFinnigan LCQ Advantage) of a
tryptic digest was used to confirm the identity of the protein.
Spy1600 assays
Assays using MU (4-methylumbelliferyl) glycosides, i.e. 2-MU-
α-D-N-acetylneuraminic acid, MU-α-D-galactoside, MU-α-D-
mannopyranoside, MU-β-D-galactoside, MU-β-D-glucuronide,
MU-β-D-mannopyranoside, MU-N-acetyl-β-D-glucosaminide,
(MU-2-acetamido-2-deoxy-β-D-glucopyranosideorMU-GlcNAc),
MU-N-acetyl-β-D-galactosaminide and the three N-fluoro-
acetyl derivatives of MU GlcNAc [Figure 1A; MU-GlcNAcF1
(MU-2-deoxy-2-fluoroacetamido-β-D-glucopyranoside), MU-
GlcNAcF2 (MU-2-deoxy-2-difluoroacetamido-β-D-glucopyra-
noside) and MU-GlcNAcF3 (MU-2-deoxy-2-trifluoroacetamido-
β-D-glucopyranoside)], were performed in triplicate and liber-
ated 4-methylumbelliferone was measured, in real time, using
a Bio-Tek FL600 fluorescence microplate reader. Fluorinated
substrates were prepared as previously described [8]. Excitation
and emission wavelengths of 360 and 460 nm respectively were
used. Standard assays were performed at 37 ◦C in a total volume
of 100 µl of 20 mM Hepes buffer, pH 7.6, containing 1.0 mg/
ml BSA and 0.25 µg of Spy1600. The ranges of substrate concen-
trations used for determining kcat and Km values were 0.5–7.0 mM
for MU-GlcNAc, 0.7–3.7 mM for MU-GlcNAcF1, 0.7–
3.7 mM for MU-GlcNAcF2 and 0.3–1.3 mM for MU-GlcNAcF3.
For the latter three substrates, 0.5 µg, 1 µg and 100 µg of enzyme
was added per 100 µl of reaction mixture respectively. Goodness-
of-fit statistical analyses of linear trendlines of the resulting
Lineweaver–Burk plots yielded r2 values of 0.9744. For inhi-
bition assays the range of concentrations of MU-GlcNAc and
NAG-thiazoline (1,2-dideoxy-2′-methyl-α-D-glucopyranoso-
[2,1-d]-2′ -thiazoline) (Figure 1B) used were 0.1, 0.3, 0.5, 0.7,
1.0, 2.0 mM and 0.41, 1.23, 3.70, 11.00, 33.00 µM respectively.
Goodness-of-fit statistical analysis of linear trendlines of the
resulting Lineweaver–Burk plots produce r2 values of 0.9744.
The buffer used for determination of the pH–activity optimum
was 20 mM Hepes (pH 6.8, 7.0, 7.2, 7.4, 7.5, 7.6, 7.8, 8.0 and 8.2).
The effect of bivalent ions on enzyme activity was determined by
adding CoCl2, MgCl2, MnCl2, BaCl2, NiCl2 and CaCl2 separately
to reactions to yield a final metal-ion concentration of 1 mM.
Assays for hyaluronidase activity were performed as described
by Miller [22]. Reaction mixtures were incubated for up to 16 h
and contained 2 mg/ml sodium hyaluronate (Fisher Scientific),
1 mg/ml BSA, 20 mM Hepes at a range of pH values (6.5–8.5)
and Spy1600 at a range of concentrations (7.5 ng–0.5 mg/ml).
Reaction mixtures containing 0.5 mg/ml Spy1600 were also
analysed using high-performance anion-exchange chromato-
graphy as described by Price et al. [23]. An identical concentration
of bovine testis hyaluronidase (Sigma) was used according to the
manufacturer’s instructions as a positive control.
1H-NMR studies of hydrolysis of MU-GlcNAc
1H-NMR spectra were collected at ambient probe temperature with
a JEOL Eclipse spectrometer operating at 270 MHz. All reactions
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Figure 2 Sequence alignments of characterized family 84 enzymes
Box-shaded ClustalW 1.82 alignment of the Hyaluronidase 2 PfamA domain of the structurally characterized family 84 bacterial enzymes BT4395 from Bacteroides thetaiotaomicron VPI-5482 and
CPE1234 from Clostridium perfringens 13 and the human (Homo sapiens) family 84 enzyme with the Streptococcus pyogenes strain SF370 family 84 enzyme Spy1600. Black background, identical
residues; grey background, similar residues; white background, different residues; asterisks, catalytic residues of BT4395, CPE1234 and the human O-GlcNAcase. Identities: B. thetaiotaomicron
versus C. perfringens, 45 %; B. thetaiotaomicron versus S. pyogenes, 32 %; B. thetaiotaomicron versus H. sapiens, 33 %; C. perfringens versus S. pyogenes, 30 %; C. perfringens versus H. sapiens,
31 %; S. pyogenes versus H. sapiens, 30 %.
were performed in 2H2O using 5-mm-long NMR tubes of total
volume 1 ml. Both Spy1600 and MU-GlcNAc were freeze-dried
and resuspended in 2H2O prior to monitoring the reactions. MU-
GlcNAc (3.3 mg/ml) was hydrolysed using 2.5 mg/ml Spy1600.
Western-blot analyses of human proteins treated with Spy1600
COS-7 cells were cultured to 75% confluence and a cell extract
was obtained as previously described [8]. The cell extract was
incubated at 37 ◦C for 36 h in the presence of 1 mM PMSF, 1 mM
2-mercaptoethanol, 10 mM imidazole (to reduce non-specific
binding to Ni–agarose) and 2 mg/ml purified Spy1600 enzyme
where appropriate. Spy1600 was removed prior to Western blot-
ting by two consecutive affinity precipitations using Ni–agarose
beads (Qiagen). The samples were electrophoresed through a
10% (w/v) polyacrylamide gel, blotted on to nitrocellulose and
probed as previously described [8].
RESULTS AND DISCUSSION
Spy1600 is produced in large quantities in E. coli and shares a
high degree of sequence similarity with the N-terminal domain of
the human O-GlcNAcase
Spy1600 is predicted to be a non-secretory protein by the SignalP
server [16] and contains a single PfamA domain, annotated
as Hyaluronidase 2 [17]. We recombinantly expressed the full-
length ORF, spy1600, in E. coli, and its product, Spy1600,
was obtained in large quantities (∼200 mg/l) as a N-terminally
hexahistidine-tagged protein. The enzyme was readily purified to
homogeneity as judged by SDS/PAGE (see the Supplementary
Figure at http://www.BiochemJ.org/bj/399/bj3990241add.htm).
Spy1600 is significantly smaller than the human family 84 O-
GlcNAcase; however, they are very similar over a ∼300-residue
stretch that coincides with the location of the Hyaluronidase 2
PfamA domain, and this level of identity includes two aspartate
residues that have been shown to be the catalytic residues in human
O-GlcNAcase [24] as well as within the structurally characterized
bacterial family 84 enzymes [10,11] (Figure 2). This observation
suggests that the Hyaluronidase 2 PfamA domain, which these
enzymes share in common, likely performs related functions in
nature, as was first proposed by Hanover [25] and more recently
demonstrated by kinetic studies [24,26,27].
Spy1600 shows no hyaluronidase activity and is only active
against β-N-acetylglucosaminides
Spy1600 and many other family 84 glycoside hydrolases are
annotated in GenBank®, GenPept and Swiss-Prot as putative
hyaluronidases. Indeed, eukaryotic O-GlcNAcases have been pro-
posed to have hyaluronidase activity on the basis of zymogram-
like assays [2]. We, however, were unable to detect any hyaluro-
nidase activity when Spy1600 was incubated with hyaluronan
using a reducing-sugar assay [22] or using high-performance
anion-exchange chromatography [23] to look for expected oligo-
saccharide breakdown products (Figure 3). Given the detection
limits of these assays, the upper limit of hyaluroniadase ac-
tivity that could be present without being observed here is
∼1 pmol · min−1 · mg−1. We also find that Spy1600 shows activity
only against β-N-acetylglucosaminides, with no detectable
activity against β-N-acetylgalactosaminides. This difference in
epimeric specificity contrasts with the family 20 β-hexosamin-
idases, which have nearly equivalent activity towards these
substrates [28], and is consistent with the behaviour of other
family 84 glycoside hydrolases [4]. We also assayed Spy1600
with several other β- and α-glycosides of methylumberlliferone
(see the list in the Experimental section) and found that none of
these are substrates. Owing to the marked sequence similarity
between Spy1600 and the N-terminal domain of human family 84
O-GlcNAcase, we expected that Spy1600 might have the ability to
remove O-GlcNAc from eukaryotic glycoproteins. Using a COS-
7 cell extract and incubating Spy1600 with these glycoproteins we
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Figure 3 High-performance anion-exchange chromatograms of sodium
hyaluronate digestions with Spy1600 and bovine testis hyaluronidase
(A) 0 min incubation with bovine testes hylauronidase; (B), 16 h incubation with bovine testes hy-
lauronidase; (C), 0 min incubation with Spy1600; (D), 16 h incubation with Spy1600. The hyalu-
ronan tetrasaccharide (‘4-mer’) and hexasaccharide (‘6-mer’) peaks can be seen on the
chromatogram of the 16 h sodium hyaluronate incubation with bovine testes hyaluronidase.
However no such peaks can be seen on the chromatogram of the 16 h sodium hyaluronate
incubation with Spy1600. On the ordinates, nC indicates nanocoulombs.
were able to show, using an anti-O-GlcNAc antibody in a Western-
blot analysis, that this enzyme effectively removed O-GlcNAc
from eukaryotic O-GlcNAc modified glycoproteins (Figure 4).
This O-GlcNAcase activity may be of importance, since Spy1600
may, at some point in the life cycle of S. pyogenes, encounter
Figure 4 Western blot of proteins from COS-7 cells incubated in the
presence or absence of Spy1600
Top panel: probed with anti-O-GlcNAc monoclonal IgM antibody; bottom panel: probed with
anti-β-actin IgG; lane 1, COS-7 cell extract + Spy1600; lane 2, COS-7 cell extract only; lane 3,
Spy1600 only; lane 4, COS-7 cell extract + boiled Spy1600. The molecular masses (in kDa) of
the marker proteins are indicated on the extreme left.
O-GlcNAc and process this modification either for purposes of
foraging or for interfering with the host cellular machinery.
Biochemical and biophysical parameters of Spy1600 are similar to
those of other GlcNAcases
The pH–activity optimum for Spy1600 towards MU-GlcNAc is
7.4. When subjected to a 20 min exposure to various temper-
atures, Spy1600 showed no significant decrease in activity after
pre-incubations at 37.6, 46.9, 49.1, 51.4 and 53.1 ◦C, but was only
33% active after a pre-incubation at 57 ◦C, and was completely
inactive after a pre-incubation at 68 ◦C. The percentage inhibition
of enzyme activity resulting from the inclusion of 1 mM bivalent
metal ions in the assays was as follows: 28% (Ba2+), 3% (Ca2+),
28% (Co2+), 3% (Mg2+), 20% (Mn2+) and 46% (Ni2+). The
kinetic parameters, kcat and Km, for Spy1600 against MU-GlcNAc,
were 32 +− 3 s−1 and 3.6 +− 0.3 mM respectively, with a kcat/Km
value of 9.0 s−1 · mM−1. The kcat and Km values for Spy1600
against MU-GlcNAc are in the same order of magnitude as those
for several other GlcNAcases [8,9,29].
Spy1600 uses substrate-assisted catalysis
Stereochemical outcome
To ascertain the stereochemical outcome of the Spy1600-cata-
lysed hydrolysis of β-D-glucosaminides, the progress of the early
stages of the enzyme-catalysed reaction was monitored using
1H NMR. Because N-acetyl-D-glucosamine undergoes mutaro-
tation only slowly in water [30], it is possible to monitor the
stereochemistry of the anomeric centre of the first-formed product
of the reaction. The equilibrium state in water at 20 ◦C is a 2:1
ratio of α- to β-anomers for N-acetyl-D-glucosamine [30].
The anomeric region of the 1H NMR spectrum of a reaction
mixture containing MU-GlcNAc at several time points after
adding Spy1600 is shown in Figure 5. The data shows that the first
product formed is, unambiguously, the β-anomer and only over
time does this species slowly mutarotate to form the α-anomer.
The assignment of the resonance at the higher chemical shift as the
α-anomer and the lower chemical shift resonance as the β-anomer
is consistent with literature values [31]. The α- and β-anomers
c© 2006 Biochemical Society
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Figure 5 1H NMR spectra of the hydrolysis of MU-GlcNAc by Spy1600
The anomeric resonances of MU-GlcNAc, α-GlcNAc and β-GlcNAc are centred (relative to water at δ 4.78 p.p.m.) on δ 5.21 p.p.m. (J 10 Hz), δ 5.14 p.p.m. (J 4.5 Hz) and δ 4.65 p.p.m.
(J 11 Hz) respectively. Trace A, MU-GlcNAc only; trace B, MU-GlcNAc + Spy1600 at t = 10 min; trace C, MU-GlcNAc + Spy1600 at t = 1 h; trace D, MU-GlcNAc + Spy1600 at t = 2 h; trace E,
MU-GlcNAc + Spy1600 at t = 16 h.
Table 1 Michaelis–Menten parameters for Spy1600 a series of 4-MU 2-N-acyl-2-deoxy-β-D-glucopyranosides
The Taft electronic parameters (σ *) used for each N-acyl substituent were obtained from [35]. Abbreviations ND, no activity detected; [E]0, total enzyme concentration.
Substrate σ * K m (mM) V max · [E]0 (µmol · min−1 · mg−1) V max · [E]0/K m (µmol · mM−1 · min−1 · mg−1)
MU-GlcNAc 0 3.58 +− 0.34 28.78 +− 2.70 8.04
MU-GlcNAcF1 0.8 5.21 +− 0.17 4.95 +− 0.16 0.95
MU-GlcNAcF2 2.0 14.07 +− 0.70 0.60 +− 0.03 0.04
MU-GlcNAcF3 2.8 ND ND ND
are also identifiable from the magnitudes of the vicinal coupling
constant, which is larger for the trans-diaxial arrangement of
the H-1 and H-2 protons of the β-anomer (11 Hz) than that ob-
served for the α-anomer (4.5 Hz). Further, comparison with a
standard of N-acetyl-D-glucosamine in solution in which the
known equilibrium position is obtained is consistent with these
assignments. Spy1600 therefore catalyses the reaction using a
retaining catalytic mechanism, consistent with the mechanism
proposed for the human family 84 enzyme [8,24], as well as
with that for β-hexosaminidases from family 20 of glycoside
hydrolases [32].
Substrate-assisted catalysis from the 2-acetamido group
To provide direct support for a role of the 2-acetamido group in
catalysis, a series of fluorinated substrate analogues were studied.
Four substrates with different levels of fluorine on the N-acetyl
group were used (Figure 1A). Since increasing the number of
fluorine-withdrawing groups decreases the nucleophilicity of the
carbonyl oxygen atom, it is expected that a commensurate de-
crease in the rate constant governing the enzyme-catalysed reac-
tion should result only if substrate-assisted catalysis is operative.
Assays using these compounds as substrates for Spy1600 revealed
Michaelian saturation kinetics for MU-GlcNAc, MU-GlcNAcF1
and MU-GlcNAcF2; however, the enzymatic activity towards the
trifluorinated derivative was too low to be accurately measured
using the assay conditions described here (Table 1; Figure 6A).
A plot of the log (Vmax · [E]0/Km) against the Taft electronic
parameter (σ ∗) of the N-acyl substituent shows a steep negative
linear correlation on increasing fluorine substitution (Figure 6B).
Such negative correlations have been previously observed for
glycoside hydrolases from families 20 and 84 that are known
to use substrate-assisted catalysis [8,9,33], yet remarkably absent
for family 3 glycoside hydrolases that use an enzymic nucleophile
[8]. Accordingly, these data strongly implicate the 2-acetamido
group of the substrate as an intramolecular nucleophile.
Inhibition of Spy1600 using NAG-thiazoline
NAG-thiazoline (Figure 1B) is a potent inhibitor of human O-
GlcNAcase [8], as well as of β-hexosaminidases from family
20 of glycoside hydrolases [8,34]. The potency of this inhibitor
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Figure 6 Activity of Spy1600 with N-fluoroacetyl derivatives of MU-GlcNAc
(A) Initial velocity of Spy1600-catalysed hydrolysis of N-fluoroacetyl derivatives of MU-GlcNAc:
, MU-GlcNAc;, MU-GlcNAcF1;H17009, MU-GlcNAcF2. (B) Linear-free-energy analysis plotting
the Taft parameter (σ *) of the N-fluoroacetyl substituent of MU-GlcNAc substrate analogues
against log (V max[E]0/K m) [log (µmol min−1 · mg−1 · K m−1)] values measured from the
substrates as shown in (A) with Spy1600.
for these enzymes is attributed to the similarity of this molecule
to the intermediate or a structurally related transition state. We
expected that if, as we propose, Spy1600 uses a mechanism
involving substrate-assisted catalysis, NAG-thiazoline should act
as a good competitive inhibitor. Indeed, when the compound
was assayed as an inhibitor of Spy1600, we observed a clear
pattern of competitive inhibition (Figure 7). Non-linear regression
analyses reveal a K i value for NAG-thiazoline of 5.82 +− 0.01 µM.
Although the inhibitor binds approx. 80-fold less tightly to
the streptococcal enzyme than it does to human O-GlcNAcase
(K i 0.070 µM), it remains an effective inhibitor of Spy1600.
Nevertheless, the observation that NAG-thiazoline is a good
inhibitor of Spy1600 is consistent with the substrate-structure
studies described above as well as with the stereochemical
outcome experiment and strongly suggests that all members of
glycoside hydrolase family 84, both eukaryotic and prokaryotic,
use a catalytic mechanism involving anchimeric assistance.
Conclusions
Spy1600 has been shown to be a family 84 glycoside hydrolase
with activity towards N-acetylglucosaminides and no activity
towards hyaluronan. Catalysis occurs via a substrate-assisted
catalytic mechanism in which the N-acetamido group of the sub-
Figure 7 Lineweaver–Burk plot of Spy1600 hydrolysis of MU-GlcNAc in the
presence of NAG-thiazoline
The concentrations of NAG-thiazoline were as follows: , 0.033; , 0.011; H17009, 0.0037;
, 0.00123; and, 0 mM.
strate acts as the nucleophile in a double-displacement reaction.
By virtue of the fact that Spy1600 is up-regulated during phago-
cytosis, it has been implicated as a virulence factor [14]. Since
this enzyme is unlikely to be secreted, as indicated by the
SignalP server [16], we propose that it is involved in the removal
of GlcNAc from a variety of glycoconjugates that are imported
into the bacterial cell during pathogenesis. Although it is form-
ally possible that the enzyme is involved in processing O-GlcNAc
from endogenous group A streptococcal proteins within the
bacterium, this appears unlikely, given that no O-GlcNAc trans-
ferase-like sequence is present in the genome sequence of this
strain of group A streptococcus. It is thus far more likely that
Spy1600 is involved in simple carbohydrate metabolism – a
proposal that is supported by the observation that ORFs adjacent
to spy1600, and therefore likely to be co-expressed with spy1600,
encode (a) a putative transcription regulator with similarity to the
transcriptional repressor of the arabinose operon, ORF spy1602,
(b) other glycosidases, including a putative β-glucosidase, ORF
spy1599, and a putative α-mannosidase, ORF spy1604, and (c)
putative sugar-binding transport proteins, ORFs spy1593 and
spy1595. This genomic organization strongly supports a role for
Spy1600 in glycan foraging, although given its up-regulation
during phagocytosis we cannot rule out a direct role in the de-
glycosylation of human O-GlcNAc proteins for the purpose of
compromising the host cell machinery.
We thank Dr Justin Perry (School of Applied Sciences, Northumbria University, Newcastle
upon Tyne, U.K.) for help with the analysis of the NMR spectra, Dr Iain Sutcliffe (School
of Applied Sciences, Northumbria University, Newcastle upon Tyne, U.K.) for discussions
about the possible role of Spy1600, and Mr Dave Wealleans and Miss Anna Lindsay
(both of the School of Applied Sciences, Northumbria University, Newcastle upon Tyne,
U.K.) for technical help with NMR and hyaluronan assays respectively. We also thank
Dr Danielle Chin and Dr Garrett Whitworth (both of the Department of Chemistry, Simon
Fraser University, Burnaby, BC, Canada) for reagents. This research was supported by
a National Sciences and Engineering Research Council of Canada (NSERC) Discovery
grant to D. J. V. M. S. M. thanks the NSERC and the Michael Smith Foundation for Health
Research for fellowships. D. J. V. is supported as a Canada Research Chair in Chemical
Glycobiology and as a scholar of the Michael Smith Foundation for Health Research.
REFERENCES
1 Coutinho, P. M. and Henrissat, B. (1999) Carbohydrate-Active Enzymes server at URL:
http://afmb.cnrs-mrs.fr/CAZY/
c© 2006 Biochemical Society
Family 84 glycosidases are β-N-acetylglucosaminidases lacking hyaluronidase activity 247
2 Heckel, D., Comtesse, N., Brass, N., Blin, N., Zang, K. D. and Meese, E. (1998) Novel
immunogenic antigen homologous to hyaluronidase in meningioma. Hum. Mol. Genet. 7,
1859–1872
3 Braidman, I., Carroll, M., Dance, N., Robinson, D., Poenaru, L., Weber, A., Dreyfus, J. C.,
Overdijk, B. and Hooghwin, G. J. (1974) Characterization of human
N-acetyl-β-hexosaminidase-C. FEBS Lett. 41, 181–184
4 Dong, D. L. and Hart, G. W. (1994) Purification and characterization of an O-GlcNAc
selective N-acetyl-β-D-glucosaminidase from rat spleen cytosol. J. Biol. Chem. 269,
19321–19330
5 Torres, C. R. and Hart, G. W. (1984) Topography and polypeptide distribution of terminal
N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for
O-linked GlcNAc. J. Biol. Chem. 259, 3308–3317
6 Comtesse, N., Maldener, E. and Meese, E. (2001) Identification of a nuclear variant of
MGEA5, a cytoplasmic hyaluronidase and a β-N-acetylglucosaminidase.
Biochem. Biophys. Res. Commun. 283, 634–640
7 Canard, B., Garnier, T., Saint-Joanis, B. and Cole, S. T. (1994) Molecular genetic analysis
of the nagH gene encoding a hyaluronidase of Clostridium perfringens. Mol. Gen. Genet.
243, 215–224
8 Macauley, M. S., Whitworth, G. E., Debowski, A. W., Chin, D. and Vocadlo, D. J. (2005)
O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of
highly selective mechanism-inspired inhibitors. J. Biol. Chem. 280, 25313–25322
9 Vocadlo, D. J. and Withers, S. G. (2005) Detailed comparative analysis of the catalytic
mechanisms of β-N-acetylglucosaminidases from families 3 and 20 of glycoside
hydrolases. Biochemistry 44, 12809–12818
10 Rao, F. V., Dorfmueller, H. C., Villa, F., Allwood, M., Eggleston, I. M. and van Aalten, D. M.
(2006) Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc
hydrolysis. EMBO J. 25, 1569–1578
11 Dennis, R. J., Taylor, E. J., Macauley, M. S., Stubbs, K. A., Turkenburg, J. P., Hart, S. J.,
Black, G. W., Vocadlo, D. J. and Davies, G. J. (2006) Structure and mechanism of a
bacterial β-glucosaminidase having O-GlcNAcase activity. Nat. Struct. Mol. Biol. 13,
365–371
12 Cunningham, M. W. (2000) Pathogenesis of group A streptococcal infections.
Clin. Microbiol. Rev. 13, 470–511
13 Carapetis, J. R., Steer, A. C., Mulholland, E. K. and Weber, M. (2005) The global burden of
group A streptococcal diseases. Lancet Infect. Dis. 5, 685–694
14 Voyich, J. M., Sturdevant, D. E., Braughton, K. R., Kobayashi, S. D., Lei, B., Virtaneva, K.,
Dorward, D. W., Musser, J. M. and DeLeo, F. R. (2003) Genome-wide protective response
used by group A Streptococcus to evade destruction by human polymorphonuclear
leukocytes. Proc. Natl. Acad. Sci. U.S.A. 100, 1996–2001
15 Sambrook, J. and Russell, D. W. (2001) Molecular Cloning: A Laboratory Manual
(3rd edn), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
16 Bendtsen, J. D., Nielsen, H., von Heijne, G. and Brunak, S. (2004) Improved prediction of
signal peptides: SignalP 3.0. J. Mol. Biol. 340, 783–795
17 Bateman, A., Coin, L., Durbin, R., Finn, R. D., Hollich, V., Griffiths-Jones, S., Khanna, A.,
Marshall, M., Moxon, S., Sonnhammer, E. L. et al. (2004) The Pfam protein families
database. Nucleic Acids Res. 32, D138–D141
18 Ferretti, J. J., McShan, W. M., Ajdic, D., Savic, D. J., Savic, G., Lyon, K., Primeaux, C.,
Sezate, S., Suvorov, A. N., Kenton, S. et al. (2001) Complete genome sequence of an M1
strain of Streptococcus pyogenes. Proc. Natl. Acad. Sci. U.S.A. 98, 4658–4663
19 Brown, I. E., Mallen, M. H., Charnock, S. J., Davies, G. J. and Black, G. W. (2001) Pectate
lyase 10A from Pseudomonas cellulosa is a modular enzyme containing a family 2a
carbohydrate-binding module. Biochem. J. 355, 155–165
20 Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram
quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72,
248–254
21 Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of
bacteriophage T4. Nature (London) 227, 680–685
22 Miller, G. L. (1959) Use of dinitrosalicylic acid reagent for determination of reducing
sugar. Anal. Chem. 31, 426–428
23 Price, K. N., Tuinman, A., Baker, D. C., Chisena, C. and Cysyk, R. L. (1997) Isolation
and characterization by electrospray-ionization mass spectrometry and high-
performance anion-exchange chromatography of oligosaccharides derived from
hyaluronic acid by hyaluronate lyase digestion: observation of some heretofore
unobserved oligosaccharides that contain an odd number of units. Carbohydr. Res. 303,
303–311
24 Cetinbas, N., Macauley, M. S., Stubbs, K. A., Drapala, R. and Vocadlo, D. J. (2006)
Identification of Asp174 and Asp175 as the key catalytic residues of human O-GlcNAcase
by functional analysis of site-directed mutants. Biochemistry 45, 3835–3844
25 Hanover, J. A. (2001) Glycan-dependent signaling: O-linked N-acetylglucosamine.
FASEB J. 15, 1865–1876
26 Ficko-Blean, E. and Boraston, A. B. (2005) Cloning, recombinant production,
crystallization and preliminary X-ray diffraction studies of a family 84 glycoside hydrolase
from Clostridium perfringens. Acta Crystallogr. F61, 834–836
27 Kim, E. J., Kang, D. O., Love, D. C. and Hanover, J. A. (2006) Enzymatic characterization
of O-GlcNAcase isoforms using a fluorogenic GlcNAc substrate. Carbohydr. Res. 341,
971–982
28 Woollen, J. W., Heyworth, R. and Walker, P. G. (1961) Studies on glucosaminidase. 3.
Testicular N-acetyl-β-glucosaminidase and N-acetyl-β-galactosaminidase. Biochem. J.
78, 111–116
29 Li, H., Morimoto, K., Katagiri, N., Kimura, T., Sakka, K., Lun, S. and Ohmiya, K. (2002)
A novel β-N-acetylglucosaminidase of Clostridium paraputrificum M-21 with high
activity on chitobiose. Appl. Microbiol. Biotechnol. 60, 420–427
30 Kuhn, R. and Haber, F. (1953) About the β-form of N-acetylglucosamine. Chem. Ber. 86,
722
31 Finar, I. L. (1973) Organic Chemistry. Fundamental Principles (Vol. 1d, 6th Ed.) Longman,
London
32 Drouillard, S., Armand, S., Davies, G. J., Vorgias, C. E. and Henrissat, B. (1997) Serratia
marcescens chitobiase is a retaining glycosidase utilizing substrate acetamido group
participation. Biochem. J. 328, 945–949
33 Jones, C. S. and Kosman, D. J. (1980) Purification, properties, kinetics, and
mechanism of β-N-acetylglucosamidase from Aspergillus niger. J. Biol. Chem. 255,
11861–11869
34 Knapp, S., Vocadlo, D., Gao, Z., Kirk, B., Lou, J. and Withers, S. (1996) NAG-thiazoline,
an N-acetyl-β-hexosaminidase inhibitor that implicates acetamido participation. J. Am.
Chem. Soc. 118, 6804–6805
35 Hansch, C. and Leo, A. (1979) Substituent constants for correlation analysis in chemistry
and biology. Wiley, New York
Received 23 February 2006/26 June 2006; accepted 6 July 2006
Published as BJ Immediate Publication 6 July 2006, doi:10.1042/BJ20060307
c© 2006 Biochemical Society
